Safety Halt in Depression Trials; New Bipolar and ADHD Data
A roundup of recent psychiatry news, including a trial pause, new drug results, and shifting youth alcohol use.
Clinical AI, drug discovery, devices, and regulatory approvals.
A roundup of recent psychiatry news, including a trial pause, new drug results, and shifting youth alcohol use.
The seed round, led by Rethink Impact, will help scale a platform focused on LGBTQ+ mental health care.
Journalist Tamsen Fadal leverages her storytelling background to spotlight menopause, a historically under-discussed women's health issue.
A systematic screen of 1,191 FDA-approved drugs identified an asthma medication as a candidate for slowing preterm labor.
A UVA Health-developed compound restored neurological function in a mouse model of multiple sclerosis, a first for a field focused on preventing attacks.
A new American Heart Association finding shows that fear and uncertainty keep many bystanders from attempting CPR in an emergency.
A Democratic report says President Trump's drugmaker stock holdings rose sharply after a 2025 law shielded some medications from Medicare price negotiations.
A new study finds that the protective effect of tuberculosis preventive treatment diminishes after about a year in high-burden settings, with implications for global TB elimination goals.
The investment aims to expand an AI-enabled platform for managing clinician staffing.
Early findings suggest the pill danegaptide could shield eyes from damage caused by nonproliferative diabetic retinopathy.
A new study suggests that sharing a meal with someone you love may help regulate blood glucose better than eating alone.
Lab tests of 39 sweeteners found many alter gut bacteria growth, and one sweetener combined with an antidepressant produced strong suppressive effects.
New research in mice reveals a soy-derived compound can ease high blood pressure, memory problems, and social deficits caused by excessive salt intake.
The anti-FcRn antibody IMVT-1402 will no longer be developed for cutaneous lupus erythematosus following a midphase trial miss.
A large observational study links high intake of Neu5Gc, a sugar in red meat, to a 63% higher type 2 diabetes risk, likely via chronic inflammation.
A weekly roundup of expert quotes covers AI's non-neutral role, vaccine access hurdles, and the real driver of advanced HIV disease.
Tracking skin stem cells in living mice reveals that female cells act in synchrony while male cells act independently, a difference tied to sex hormones.
CEO David Ricks says Lilly dominates the expanding Medicare GLP-1 coverage program, which now includes 700,000 seniors.